COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations.

IF 2.4 Q3 INFECTIOUS DISEASES Tropical Diseases, Travel Medicine and Vaccines Pub Date : 2020-08-28 eCollection Date: 2020-01-01 DOI:10.1186/s40794-020-00118-y
Gerard Thomas Flaherty, Paul Hession, Chee Hwui Liew, Bryan Chang Wei Lim, Tan Kok Leong, Victor Lim, Lokman Hakim Sulaiman
{"title":"COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations.","authors":"Gerard Thomas Flaherty, Paul Hession, Chee Hwui Liew, Bryan Chang Wei Lim, Tan Kok Leong, Victor Lim, Lokman Hakim Sulaiman","doi":"10.1186/s40794-020-00118-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A high burden of severe disease and death from the coronavirus disease 2019 (COVID-19) has been consistently observed in older patients, especially those with pre-existing medical co-morbidities. The global pandemic lockdown has isolated many patients with chronic illnesses from their routine medical care. This narrative review article analyses the multitude of issues faced by individuals with underlying medical conditions during the COVID-19 pandemic.</p><p><strong>Methods: </strong>Sources for this publication were identified through searches of PubMed for articles published between 31st December 2019 and 4th June 2020, using combinations of search terms. Guidelines and updates from reputable agencies were also consulted. Only articles published in the English language were included.</p><p><strong>Results: </strong>The volume of literature on COVID-19 continues to expand, with 17,845 articles indexed on PubMed by 4th June 2020, 130 of which were deemed particularly relevant to the subject matter of this review. Older patients are more likely to progress to severe COVID-19 disease requiring intensive care unit (ICU) admission. Patients with pre-existing cardiovascular disease, especially hypertension and coronary heart disease, are at greatly increased risk of developing severe and fatal COVID-19 disease. A controversial aspect of the management of COVID-19 disease has been the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Obese COVID-19 patients are more likely to require complex ICU management. Putative mechanisms of increased COVID-19 disease severity in diabetes include hyperglycaemia, altered immune function, sub-optimal glycaemic control during hospitalisation, a pro-thrombotic and pro-inflammatory state. Patients with mental health disorders are particularly vulnerable to social isolation, and this has been compounded by the suspension of non-emergency care in hospitals around the world, making it difficult for patients with chronic mental illness to attend outpatient appointments.</p><p><strong>Conclusions: </strong>The global pandemic of COVID-19 disease has had a disproportionately negative impact on patients living with chronic medical illness. Future research should be directed at efforts to protect vulnerable patients from possible further waves of COVID-19 and minimising the negative impact of pandemic mitigation strategies on these individuals.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"6 ","pages":"16"},"PeriodicalIF":2.4000,"publicationDate":"2020-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40794-020-00118-y","citationCount":"83","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tropical Diseases, Travel Medicine and Vaccines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40794-020-00118-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 83

Abstract

Background: A high burden of severe disease and death from the coronavirus disease 2019 (COVID-19) has been consistently observed in older patients, especially those with pre-existing medical co-morbidities. The global pandemic lockdown has isolated many patients with chronic illnesses from their routine medical care. This narrative review article analyses the multitude of issues faced by individuals with underlying medical conditions during the COVID-19 pandemic.

Methods: Sources for this publication were identified through searches of PubMed for articles published between 31st December 2019 and 4th June 2020, using combinations of search terms. Guidelines and updates from reputable agencies were also consulted. Only articles published in the English language were included.

Results: The volume of literature on COVID-19 continues to expand, with 17,845 articles indexed on PubMed by 4th June 2020, 130 of which were deemed particularly relevant to the subject matter of this review. Older patients are more likely to progress to severe COVID-19 disease requiring intensive care unit (ICU) admission. Patients with pre-existing cardiovascular disease, especially hypertension and coronary heart disease, are at greatly increased risk of developing severe and fatal COVID-19 disease. A controversial aspect of the management of COVID-19 disease has been the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Obese COVID-19 patients are more likely to require complex ICU management. Putative mechanisms of increased COVID-19 disease severity in diabetes include hyperglycaemia, altered immune function, sub-optimal glycaemic control during hospitalisation, a pro-thrombotic and pro-inflammatory state. Patients with mental health disorders are particularly vulnerable to social isolation, and this has been compounded by the suspension of non-emergency care in hospitals around the world, making it difficult for patients with chronic mental illness to attend outpatient appointments.

Conclusions: The global pandemic of COVID-19 disease has had a disproportionately negative impact on patients living with chronic medical illness. Future research should be directed at efforts to protect vulnerable patients from possible further waves of COVID-19 and minimising the negative impact of pandemic mitigation strategies on these individuals.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
已存在慢性心脏、呼吸和代谢疾病的成年患者感染COVID-19:一项具有临床建议的重要文献综述
背景:在老年患者中一直观察到2019年冠状病毒病(COVID-19)严重疾病和死亡的高负担,特别是那些先前存在医疗合并症的患者。全球大流行的封锁使许多慢性疾病患者与常规医疗隔离。这篇叙述性综述文章分析了COVID-19大流行期间患有潜在疾病的个人面临的众多问题。方法:通过使用搜索词组合在PubMed中搜索2019年12月31日至2020年6月4日之间发表的文章,确定该出版物的来源。还咨询了著名机构的指导方针和最新情况。只包括以英文发表的文章。结果:关于COVID-19的文献量继续扩大,截至2020年6月4日,PubMed上已有17,845篇文章被索引,其中130篇被认为与本综述的主题特别相关。老年患者更有可能发展为需要入住重症监护病房(ICU)的严重COVID-19疾病。已有心血管疾病,特别是高血压和冠心病的患者发生严重和致命的COVID-19疾病的风险大大增加。COVID-19疾病管理的一个有争议的方面是使用血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂。肥胖的COVID-19患者更可能需要复杂的ICU管理。糖尿病患者COVID-19疾病严重程度增加的推测机制包括高血糖、免疫功能改变、住院期间血糖控制不理想、促血栓和促炎症状态。精神疾病患者特别容易受到社会孤立,而世界各地医院暂停非紧急护理使这种情况更加严重,使慢性精神疾病患者难以参加门诊预约。结论:2019冠状病毒病全球大流行对慢性内科疾病患者产生了不成比例的负面影响。未来的研究应侧重于保护脆弱的患者免受COVID-19可能出现的进一步浪潮的影响,并尽量减少大流行缓解策略对这些人的负面影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.20
自引率
0.00%
发文量
25
审稿时长
17 weeks
期刊介绍: Tropical Diseases, Travel Medicine and Vaccines is an open access journal that considers basic, translational and applied research, as well as reviews and commentary, related to the prevention and management of healthcare and diseases in international travelers. Given the changes in demographic trends of travelers globally, as well as the epidemiological transitions which many countries are experiencing, the journal considers non-infectious problems including chronic disease among target populations of interest as well as infectious diseases.
期刊最新文献
Monkeypox: a re-emergent virus with global health implications - a comprehensive review. Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems. The application of aptamer in tuberculosis diagnosis: a systematic review. Significance of climate change in the emergence of human fascioliasis in Upper Egypt. Exploring plant-based dengue therapeutics: from laboratory to clinic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1